laryngeal squamous cell carcinoma (Cancer)
Information
- Disease name
- laryngeal squamous cell carcinoma
- Disease ID
- DOID:2876
- Description
- "A laryngeal carcinoma that has_material_basis_in squamous cells." [url:http\://en.wikipedia.org/wiki/Squamous-cell_carcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04030455 | Active, not recruiting | Phase 2 | Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer | August 7, 2019 | March 1, 2025 |
| NCT05551117 | Active, not recruiting | Phase 2 | A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors | June 13, 2023 | May 2027 |
| NCT03258554 | Active, not recruiting | Phase 2/Phase 3 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | April 3, 2018 | September 21, 2024 |
| NCT01314755 | Completed | N/A | A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer | November 2003 | July 2008 |
| NCT06137378 | Not yet recruiting | Phase 2 | European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | November 2024 | December 2030 |
| NCT05832593 | Not yet recruiting | Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy. | May 1, 2023 | January 2025 | |
| NCT06084845 | Not yet recruiting | Phase 2 | Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer | April 12, 2024 | May 31, 2028 |
| NCT05333523 | Recruiting | Phase 3 | Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study. | November 10, 2023 | December 1, 2028 |
| NCT02734537 | Recruiting | Phase 2 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery | November 23, 2016 | December 31, 2027 |
| NCT05136196 | Recruiting | Phase 2 | BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study | December 6, 2022 | September 1, 2024 |
| NCT02582008 | Terminated | Early Phase 1 | Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | January 2016 | September 6, 2019 |
| NCT05293327 | Unknown status | IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate | June 2022 | June 2023 |
- Disase is a (Disease Ontology)
- DOID:2600
- Cross Reference ID (Disease Ontology)
- MESH:D000077195
- Cross Reference ID (Disease Ontology)
- NCI:C4044
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:707358000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0280324
- Exact Synonym (Disease Ontology)
- Epidermoid carcinoma of the Larynx
- Exact Synonym (Disease Ontology)
- squamous cell carcinoma of larynx